pharma · Juvenile idiopathic arthritis · juvenile idiopathic arthritis
Alfasigma
Alfasigma S.p.A.
Alfasigma S.p.A is a pharma organization headquartered in BOLOGNA, IT. Primary therapeutic focus areas include Juvenile idiopathic arthritis, juvenile idiopathic arthritis, Axial Spondyloarthritis, Ulcerative colitis, Rh
BOLOGNA, IT HQ
2,481 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- BOLOGNA, IT
- Employees
- 2,481
- Programs
- 8
- Drugs
- 8
- Patents
- 25
VE-CIP1002/2021
Phase 1 · other · chronic intestinal pseudo-obstruction (CIPO)
VE-CIP1002/2021 for chronic intestinal pseudo-obstruction (CIPO) is a Phase 1 program (other) at Alfasigma S.p.A. with 1 ClinicalTrials.gov record(s).
Internal code VE-CIP1002/2021
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Alfasigma S.p.A.
- Phase
- Phase 1
- Modality
- other
- Indication
- chronic intestinal pseudo-obstruction (CIPO)
- Status
- active
- Trials
- 1